Papers
2
Total Citations
11
H-Index
2
About
Dr. Mu‑Gen Dai is a leading hepatobiliary surgeon whose research focuses on advancing minimally invasive surgical techniques for hepatocellular carcinoma (HCC). His major contributions center on comparing the safety and efficacy of laparoscopic versus robotic complex hepatectomy, particularly for solitary HCC. Through rigorous multicenter propensity score‑matched analyses, Dr. Dai has demonstrated that robotic approaches can reduce perioperative morbidity, offering critical insights into optimizing surgical outcomes. His landmark 2024 study, cited nine times, provides robust evidence for the growing role of robotic surgery in complex liver resections. This work has already influenced clinical decision‑making and sparked further investigation into robotic hepatectomy’s advantages. Dr. Dai’s research is notable for its methodological rigor and real‑world applicability, bridging the gap between technological innovation and patient care. His findings are essential reading for surgeons and researchers exploring the frontiers of minimally invasive oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2